Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 19

FDA approve RANOLAZINE

Comment Full text

RECORDATI RARE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 17

FDA approve OSILODROSTAT PHOSPHATE

Comment Full text

ALCON LABS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 20

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

MYLAN

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 17

FDA approve ALMOTRIPTAN MALATE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 14

FDA approve CARBIDOPA; ENTACAPONE; LEVODOPA

Comment Full text

ALCON LABS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 18

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

STIRA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 22

FDA approve ZINC CHLORIDE

Comment Full text

ALCON LABS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 22

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

MSN

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 21

FDA approve RUFINAMIDE

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 19

FDA approve DIVALPROEX SODIUM

Comment Full text
  • Previous
  • 56
  • 57
  • 58
  • 59
  • 60
  • Next

Search

News categories

  • Technical Exchange News(9492)
  • Event(407)
  • SEC News(155849)
  • FDA Approval(8880)
  • Company Report(721)
  • Business News(105727)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin